stockportfolio.pro
Stocks / RVMD vs ZTS
RVMD vs ZTS
Revolution Medicines, Inc. and Zoetis Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Revolution Medicines, Inc. (RVMD) | Zoetis Inc. (ZTS) | |
|---|---|---|
| Market cap | $31.3B | $33.5B |
| Revenue (latest FY) | $0 | $9.47B |
| Net income (latest FY) | $-1.13B | $2.67B |
| Revenue growth (5y CAGR) | — | 7.2% |
| Net margin | — | 28.2% |
| Return on equity | -69.3% | 78.3% |
| P/E ratio | — | 13.1 |
| Dividend yield | — | 2.7% |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open RVMD — free Open ZTS — freeFrequently asked questions
Which is bigger, RVMD or ZTS?
Zoetis Inc. is larger by market capitalization — $33.5B versus $31.3B.
Which grows faster, RVMD or ZTS?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.